ArticleMolecular cytogenetics2025
Optical genome mapping enhances cytogenetic analysis in recurrent miscarriage: confirmation of a suspected (1;10) chromosomal translocation.
Article in Molecular cytogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Cytogenomics and optical genome mapping approaches characterize a derivative interstitial monosomy 18p due to a maternal complex intrachromosomal rearrangement.Molecular cytogenetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOptical genome mapping (OGM) is a next-generation cytogenetic technique that may be beneficial for detecting subtle structural chromosomal alterations that can go unnoticed with conventional studies in couples with recurrent pregnancy loss. CASE PRESENTATION: We report the case of a couple referred to our assisted reproduction unit due to a history of recurrent pregnancy loss. Initially, conventional cytogenetic studies were performed to identify a possible genetic cause. To this end, the karyotypes of both members of the couple were determined. The fetal tissue from the third miscarriage was analyzed using comparative genome hybridization (CGH) array. Subsequently, the cytogenetic analysis of the couple was extended with the OGM technique. Basic infertility studies revealed normal results, and the karyotypes of both partners were initially reported as normal with respect to structural abnormalities. Following the third miscarriage, an array CGH analysis of the abortive tissue detected a deletion-duplication on chromosomes 1 and 10, respectively. Moreover, OGM revealed a balanced translocation between chromosomes 1 and 10 in the male which had not been detected through conventional karyotyping. A retrospective review of the karyotype by an expert cytogeneticist identified an apparent translocation that had previously gone unrecognized.
conclusionsStructural chromosomal abnormalities may be underestimated in couples experiencing multiple miscarriages because they are not always accurately recognized by conventional cytogenetic techniques. OGM offers a valuable complement to these traditional methods by identifying chromosomal alterations that may have been overlooked by karyotyping, precisely characterizing the nature of the structural rearrangements. While OGM cannot currently replace karyotyping due to limitations such as the inability to detect certain translocations (e.g., Robertsonian translocations), it can enhance diagnostic accuracy and provide additional insights into the genetic causes of repeated pregnancy loss. Therefore, OGM may serve as a useful supplementary tool for improving diagnosis and management in affected couples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.